Nantahala Capital Management’s Lucid Diagnostics LUCD Stock Holding History

Nantahala Capital Management’s Portfolio LUCD Stock Details LUCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-94,541	Closed	-$103K	–	167
2025 Q4	$103K	Hold	94,541	–	–	﹤0.01%	150
2025 Q3	$95.5K	Hold	94,541	–	–	﹤0.01%	151
2025 Q2	$109K	Hold	94,541	–	–	﹤0.01%	152
2025 Q1	$141K	Hold	94,541	–	–	0.01%	140
2024 Q4	$77.4K	Sell	94,541 -31,821	-25%	-$28.1K	﹤0.01%	132
2024 Q3	$103K	Hold	126,362	–	–	0.01%	132
2024 Q2	$104K	Sell	126,362 -23,336	-16%	-$19.8K	0.01%	125
2024 Q1	$132K	Hold	149,698	–	–	0.01%	114
2023 Q4	$211K	Sell	149,698 -8,437	-5%	-$11.1K	0.01%	119
2023 Q3	$185K	Sell	158,135 -40,939	-21%	-$59.4K	0.02%	122
2023 Q2	$277K	Sell	199,074 -62,590	-24%	-$94.3K	0.03%	109
2023 Q1	$377K	Sell	261,664 -17,873	-6%	-$24.7K	0.03%	108
2022 Q4	$380K	Sell	279,537 -6,895	-2%	-$12.4K	0.02%	102
2022 Q3	$438K	Sell	286,432 -22,546	-7%	-$56.1K	0.03%	98
2022 Q2	$698K	Sell	308,978 -6,436	-2%	-$14.3K	0.04%	103
2022 Q1	$1.06M	Sell	315,414 -119,641	-28%	-$437K	0.05%	100
2021 Q4	$2.34M	Buy	+435,055	New	+$3.53M	0.08%	101

Other funds holding LUCD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Nantahala Capital Management's LUCD Position: Q1 2026 in Review

Nantahala Capital Management sold out of Lucid Diagnostics (LUCD) in Q1 2026, closing a stake of 94,541 shares — an estimated $103K sold.

Nantahala Capital Management first reported a position in LUCD in Q4 2021 and held it in 17 quarters. The position peaked at $2.34M in Q4 2021. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.

Nantahala Capital Management reported no remaining Lucid Diagnostics position as of Q1 2026 after selling out during the quarter.
Nantahala Capital Management sold 94,541 Lucid Diagnostics shares in Q1 2026, an estimated $103K.
Nantahala Capital Management first reported a position in Lucid Diagnostics in Q4 2021 and held it in 17 quarters.
Nantahala Capital Management's Lucid Diagnostics position peaked at $2.34M in Q4 2021.
103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.

Based on Nantahala Capital Management's 13F filing for Q1 2026, filed 15 May 2026.